newest glp-1 drug New study shows popular weight loss may slow biological aging How GLP-1 medications are transforming

2024Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the surmount-4 randomized clinical trial

Provider reviews eligibility

Food and Drug Administration (FDA or the Agency) publicly released a new batch of thirty Warning Letters directed at telehealth companies and online wellness clinics accused of making false or misleading claims about compounded versions of popular glucagon-like peptide-1 (GLP-1) receptor agonist medications

The best path forward with semaglutide is to work with a knowledgeable healthcare provider who can help you find the right dosage where you can see results but also minimize side effects

Products that have not undergone clinical testing